171 related articles for article (PubMed ID: 7781437)
1. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.
Maeda T; Onishi S; Miura T; Iwamura S; Tomita A; Saibara T; Yamamoto Y
Dig Dis Sci; 1995 Jun; 40(6):1226-30. PubMed ID: 7781437
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.
Makris M; Preston FE; Triger DR; Underwood JC; Westlake L; Adelman MI
Blood; 1991 Oct; 78(7):1672-7. PubMed ID: 1912556
[TBL] [Abstract][Full Text] [Related]
3. [A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid].
Saitoh S; Yamada T; Satoh K; Makita F; Ojima T; Nishijima K; Chishima J; Yamada S; Takagi H; Nagamine T
Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2152-6. PubMed ID: 8411755
[No Abstract] [Full Text] [Related]
4. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
Carreño V; Tapia L; Ryff JC; Quiroga JA; Castillo I
J Med Virol; 1992 Jul; 37(3):215-9. PubMed ID: 1331310
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S
Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784
[TBL] [Abstract][Full Text] [Related]
7. alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.
Di Marco V; Lo Iacono O; Capra M; Grutta S; Ciaccio C; Gerardi C; Maggio A; Renda D; Almasio P; Pisa R
Haematologica; 1992; 77(6):502-6. PubMed ID: 1289187
[TBL] [Abstract][Full Text] [Related]
8. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
Bresci G; Del Corso L; Romanelli AM; Giuliano G; Pentimone F
J Am Geriatr Soc; 1993 Aug; 41(8):857-62. PubMed ID: 7688007
[TBL] [Abstract][Full Text] [Related]
9. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
Hirashima N; Mizokami M; Orito E; Yamauchi M; Narita M; Mizuno M; Tokuda Y; Nakano T; Kato M; Matsumoto T
Intern Med; 1994 May; 33(5):300-2. PubMed ID: 7949634
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection.
D'Amico E; Paroli M; Fratelli V; Palazzi C; Barnaba V; Callea F; Consoli G
Dig Dis Sci; 1995 Oct; 40(10):2113-6. PubMed ID: 7587775
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
Protzer U; Ochsendorf FR; Leopolder-Ochsendorf A; Holtermüller KH
Gastroenterology; 1993 Mar; 104(3):903-5. PubMed ID: 8440441
[TBL] [Abstract][Full Text] [Related]
13. [A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C].
Fernández I; Castellano G; Canga F; Colina F; García H; Fuertes A; Casis B; Martín A; Solís JA
Gastroenterol Hepatol; 1995 Feb; 18(2):66-72. PubMed ID: 7621277
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
[TBL] [Abstract][Full Text] [Related]
15. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
[TBL] [Abstract][Full Text] [Related]
16. A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C.
Hakozaki Y; Shirahama T; Katou M; Nakagawa K; Oba K; Mitamura K
Am J Gastroenterol; 1995 Aug; 90(8):1246-9. PubMed ID: 7639224
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
De Bac C; Grimaldi F; Clementi C; Duca F; Livoli D; Taliani G
Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
[TBL] [Abstract][Full Text] [Related]
18. [Interferon therapy in hepatitis C].
Ferenci P
Wien Med Wochenschr; 1993; 143(16-17):461-4. PubMed ID: 8273373
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.
Bedossa P; Poynard T; Mathurin P; Lemaigre G; Chaput JC
Gut; 1993; 34(2 Suppl):S146-7. PubMed ID: 8314486
[TBL] [Abstract][Full Text] [Related]
20. Interferon alfa for chronic hepatitis C in haemophiliacs.
Makris M; Preston FE; Triger DR; Underwood JC; Westlake L; Adelman MI
Gut; 1993; 34(2 Suppl):S121-3. PubMed ID: 8314476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
